top of page
Dr. Mingshan Xue Named 2025 Oxford-Harrington Rare Disease Scholar; Validating Project CASK-Funded Gene Therapy Research
Project CASK identified Dr. Mingshan Xue's gene replacement therapy research in 2023 and committed $375,000 in 2024. In 2025, Dr. Xue was named an Oxford-Harrington Rare Disease Scholar — one of the most selective therapeutic development honors in the world. A validation of parent-led science.
Hitomi Kubo
Nov 20, 20252 min read
bottom of page